Classes
Publications
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Faculty of Mathematics and Physics
- Biological therapy of Crohn's disease2012 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | First Faculty of Medicine
- The options of medicamentous therapy in Crohn's disease and ulcerative colitis +12011 | First Faculty of Medicine
- Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer +12010 | First Faculty of Medicine
- Biological therapy of Crohn's disease and ulcerative colitis2008 | First Faculty of Medicine
- Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?2023 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy2023 | Faculty of Science, First Faculty of Medicine, Second Faculty of Medicine
- Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD2023 | Faculty of Science, First Faculty of Medicine, Second Faculty of Medicine
- On the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases2023 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...